The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Charles Stanley And Nomura Cut Standard Chartered

Wed, 29th Oct 2014 09:41

LONDON (Alliance News) - The following UK shares received analyst recommendations Wednesday morning and late Tuesday:
----------
FTSE 100
----------
S&P CAPITAL IQ RAISES BG GROUP TO 'HOLD' ('SELL') - PRICE TARGET 1050 PENCE
----------
BARCLAYS CUTS BG GROUP PRICE TARGET TO 1300 (1350) PENCE - 'EQUAL WEIGHT'
----------
UBS RAISES ITV PRICE TARGET TO 230 (210) PENCE - 'BUY'
----------
CREDIT SUISSE CUTS PETROFAC PRICE TARGET TO 1250 (1340) PENCE
----------
UBS CUTS STANDARD CHARTERED PRICE TARGET TO 1120 (1315) PENCE - 'BUY'
----------
GOLDMAN CUTS STANDARD CHARTERED PRICE TARGET TO 1130 (1240) PENCE - 'NEUTRAL'
----------
TRADERS: NOMURA CUTS STANDARD CHARTERED TO 'NEUTRAL' ('BUY')
----------
EXANE BNP CUTS STANDARD CHARTERED PRICE TARGET TO 1000 (1260) PENCE - UNDERPERFORM
----------
HSBC CUTS STANDARD CHARTERED PRICE TARGET TO 950 (1150) PENCE - 'UNDERWEIGHT'
----------
NUMIS CUTS STANDARD CHARTERED PRICE TARGET TO 1000 (1200) PENCE - 'HOLD'
----------
CHARLES STANLEY CUTS STANDARD CHARTERED TO HOLD (ACCUMULATE) - TARGET 1150 (1400) PENCE
----------
Deutsche Bank Cuts Standard Life Price Target To 445p From 455p, Buy
----------
MORGAN STANLEY RAISES ANGLO AMERICAN PRICE TARGET TO 1500 (1440) PENCE - 'UNDERWEIGHT.'
----------
LBBW CUTS BP PRICE TARGET TO 520 (550) PENCE - 'BUY'
----------
TRADERS: BERNSTEIN RAISES ROLLS-ROYCE TO 'MARKET-PERFORM' ('UNDERPERFORM')
----------
FTSE 250
----------
CREDIT SUISSE CUTS AMEC PRICE TARGET TO 1070 (1150) PENCE
----------
CREDIT SUISSE CUTS JOHN WOOD PRICE TARGET TO 790 (890) PENCE
----------
LIBERUM RAISES BELLWAY PRICE TARGET TO 1990 (1764) PENCE - 'BUY'
----------
EXANE BNP CUTS SYNTHOMER PRICE TARGET TO 205 (215) PENCE - 'NEUTRAL'
----------
HSBC CUTS SYNTHOMER PRICE TARGET TO 220 (230) PENCE - 'NEUTRAL'
----------
JEFFERIES CUTS SYNTHOMER PRICE TARGET TO 275 (314) PENCE - 'BUY'
----------
MAIN MARKET AND AIM
----------
BARCLAYS RAISES VECTURA GROUP PRICE TARGET TO 175 (171) PENCE - 'OVERWEIGHT'
----------
JEFFERIES CUTS IMAGINATION TECHNOLOGIES PRICE TARGET TO 242 (300) PENCE - 'BUY'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
19 Mar 2021 09:46

BROKER RATINGS: Barclays and Goldman Sachs downgrade Hammerson

BROKER RATINGS: Barclays and Goldman Sachs downgrade Hammerson

Read more
18 Mar 2021 10:36

Vectura shares rise on swing to profit, GBP115 million special payout

Vectura shares rise on swing to profit, GBP115 million special payout

Read more
18 Mar 2021 07:43

Royalty income, litigation win see Vectura beat expectations

(Sharecast News) - Vectura reported a 6.9% improvement in its total revenue on Thursday, to £190.6m, driven by development services and a surge in income from royalties.

Read more
11 Mar 2021 16:13

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
5 Mar 2021 12:29

Vectura delays results because of KPMG staff shortage

(Sharecast News) - Vectura delayed the publication of its annual results after KPMG asked for more time to audit the accounts because of a staff shortage caused by Covid-19.

Read more
2 Mar 2021 16:01

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
22 Jan 2021 09:32

LONDON BROKER RATINGS SUMMARY: Deutsche Bank Ups British Land, Landsec

LONDON BROKER RATINGS SUMMARY: Deutsche Bank Ups British Land, Landsec

Read more
12 Jan 2021 10:13

Vectura Forecasts 2020 Earnings To Top Board Expectations

Vectura Forecasts 2020 Earnings To Top Board Expectations

Read more
12 Jan 2021 08:16

Vectura reports 'strong' operational performance in 2020

(Sharecast News) - Inhaled medicines-focussed pharmaceutical company Vectura Group updated the market on its trading on Tuesday, saying it expected revenue and adjusted EBITDA for 2020 to be ahead of board expectations, following the fourth quarter approval of VR315 (US), or generic 'Advair', alongside Hikma.

Read more
30 Dec 2020 19:10

UK EXECUTIVE CHANGE SUMMARY: Nutrition Firm Director Joins Tate & Lyle

UK EXECUTIVE CHANGE SUMMARY: Nutrition Firm Director Joins Tate & Lyle

Read more
29 Dec 2020 12:04

Vectura Says Glaxo Will Not Appeal Award In Ellipta Litigation

Vectura Says Glaxo Will Not Appeal Award In Ellipta Litigation

Read more
29 Dec 2020 10:04

Glaxo not seeking re-hearing in Ellipta litigation, says Vectura

(Sharecast News) - Vectura said on Tuesday that GlaxoSmithKline has not sought to petition the US Court of Appeals for a re-hearing in the companies' ongoing litigation over GSK's Ellipta inhalers.

Read more
18 Dec 2020 17:08

LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal

LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal

Read more
18 Dec 2020 12:08

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

Read more
18 Dec 2020 10:45

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.